{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:59:43Z","timestamp":1793134783462,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jconrel.2024.06.005","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T17:44:38Z","timestamp":1718387078000},"page":"85-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["PEG length effect of peptide-functional liposome for blood brain barrier (BBB) penetration and brain targeting"],"prefix":"10.1016","volume":"372","author":[{"given":"Qiuli","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.06.005_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0015","article-title":"Development of novel therapeutics targeting the blood-brain barrier: from barrier to carrier","volume":"8","author":"Li","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0025","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.tibtech.2018.01.006","article-title":"Nanotechnology-based strategies for siRNA brain delivery for disease therapy","volume":"36","author":"Zheng","year":"2018","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0030","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0040","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0045","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1039\/C8CS00805A","article-title":"Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics","volume":"48","author":"Tang","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0050","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jconrel.2022.09.046","article-title":"Brain-targeted CRISPR\/Cas9 nanomedicine for effective glioblastoma therapy","volume":"351","author":"Ruan","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201803717","article-title":"Effective and targeted human orthotopic glioblastoma xenograft therapy via a multifunctional biomimetic nanomedicine","volume":"30","author":"Zou","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0060","doi-asserted-by":"crossref","first-page":"eabm8011","DOI":"10.1126\/sciadv.abm8011","article-title":"Blood-brain barrier-penetrating single CRISPR-cas9 nanocapsules for effective and safe glioblastoma gene therapy","volume":"8","author":"Zou","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0065","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/acsnano.8b05265","article-title":"Apolipoprotein E peptide-directed chimeric polymersomes mediate an ultrahigh-efficiency targeted protein therapy for glioblastoma","volume":"12","author":"Jiang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0070","doi-asserted-by":"crossref","first-page":"20210274","DOI":"10.1002\/EXP.20210274","article-title":"Brain co-delivery of first-line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy","volume":"2","author":"Liu","year":"2022","journal-title":"Exploration"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0075","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.1002\/anie.201914751","article-title":"Systemic brain delivery of antisense oligonucleotides across the blood-brain barrier with a glucose-coated polymeric nanocarrier","volume":"59","author":"Min","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0080","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41551-021-00803-z","article-title":"Conjugation of glucosylated polymer chains to checkpoint blockade antibodies augments their efficacy and specificity for glioblastoma","volume":"5","author":"Yang","year":"2021","journal-title":"Nat. Biomed."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0085","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jconrel.2021.07.048","article-title":"Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo","volume":"337","author":"Wei","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0090","doi-asserted-by":"crossref","first-page":"1902604","DOI":"10.1002\/adma.201902604","article-title":"Ligand-installed nanocarriers toward precision therapy","volume":"32","author":"Mi","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2022.09.002","article-title":"Stealth nanoparticles in oncology: facing the PEG dilemma","volume":"351","author":"Zalba","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0100","doi-asserted-by":"crossref","first-page":"114079","DOI":"10.1016\/j.addr.2021.114079","article-title":"To pegylate or not to pegylate: immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives","volume":"180","author":"Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0105","doi-asserted-by":"crossref","first-page":"20220045","DOI":"10.1002\/EXP.20220045","article-title":"Advanced strategies to evade the mononuclear phagocyte system clearance of nanomaterials","volume":"3","author":"Lu","year":"2023","journal-title":"Exploration"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae - the first fda-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0120","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1158\/1078-0432.CCR-03-0655","article-title":"Phase I and pharmacokinetic study of genexol-pm, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies","volume":"10","author":"Kim","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actbio.2016.07.015","article-title":"Pegylated pamam dendrimers: enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery","volume":"43","author":"Luong","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0130","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1021\/bc700483s","article-title":"Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity","volume":"19","author":"Kim","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0135","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1049\/mnl.2017.0457","article-title":"Effect of PEI surface modification with PEG on cytotoxicity and transfection efficiency","volume":"13","author":"Saqafi","year":"2018","journal-title":"Micro. Nano Lett."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0140","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1023\/A:1008365716693","article-title":"Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg\/m2","volume":"11","author":"Safra","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0145","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1021\/acsnano.6b02708","article-title":"Tuning the selectivity of dendron micelles through variations of the poly(ethylene glycol) corona","volume":"10","author":"Pearson","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0150","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1021\/nn305663e","article-title":"A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes","volume":"7","author":"Stefanick","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0155","doi-asserted-by":"crossref","first-page":"12203","DOI":"10.1021\/acsami.6b16556","article-title":"Impact of PEG chain length on the physical properties and bioactivity of pegylated chitosan\/siRNA nanoparticles in vitro and in vivo","volume":"9","author":"Yang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0160","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1039\/c3nr05559k","article-title":"Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between pegylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells","volume":"6","author":"Pozzi","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0165","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/acsami.8b18843","article-title":"Ligand density and linker length are critical factors for multivalent nanoparticle-receptor interactions","volume":"11","author":"Abstiens","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0170","doi-asserted-by":"crossref","first-page":"10130","DOI":"10.1021\/acsnano.8b04947","article-title":"Dense and dynamic polyethylene glycol shells cloak nanoparticles from uptake by liver endothelial cells for long blood circulation","volume":"12","author":"Zhou","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0175","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1021\/nl302638g","article-title":"Pegylated print nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics","volume":"12","author":"Perry","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0180","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/ja2084338","article-title":"Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake","volume":"134","author":"Walkey","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0185","doi-asserted-by":"crossref","first-page":"18419","DOI":"10.1021\/jacs.2c06877","article-title":"Engineering poly(ethylene glycol) nanoparticles for accelerated blood clearance inhibition and targeted drug delivery","volume":"144","author":"Tian","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0190","article-title":"Size, shape, and flexibility influence nanoparticle transport across brain endothelium under flow","volume":"5","author":"Nowak","year":"2019","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12951-015-0075-7","article-title":"The effect of nanoparticle size on the probability to cross the blood-brain barrier: An in-vitro endothelial cell model","volume":"13","author":"Shilo","year":"2015","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/17425247.2014.950564","article-title":"The importance of nanoparticle shape in cancer drug delivery","volume":"12","author":"Truong","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0205","doi-asserted-by":"crossref","first-page":"15322","DOI":"10.1038\/ncomms15322","article-title":"Surface chemistry governs cellular tropism of nanoparticles in the brain","volume":"8","author":"Song","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0210","doi-asserted-by":"crossref","first-page":"2102001","DOI":"10.1002\/advs.202102001","article-title":"Tuning the elasticity of polymersomes for brain tumor targeting","volume":"8","author":"Zheng","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0215","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jconrel.2020.09.042","article-title":"Transport of pegylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and brain bioavailability","volume":"328","author":"Rabanel","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nano.2018.11.016","article-title":"Length of surface PEG modulates nanocarrier transcytosis across brain vascular endothelial cells","volume":"16","author":"Tehrani","year":"2019","journal-title":"Nanomed-Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0230","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1158\/1078-0432.CCR-19-3258","article-title":"Ang1005, a brain-penetrating peptide-drug conjugate, shows activity in patients with breast cancer with leptomeningeal carcinomatosis and recurrent brain metastases","volume":"26","author":"Kumthekar","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0235","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.biomaterials.2018.02.026","article-title":"Liposomes of dimeric artesunate phospholipid: a combination of dimerization and self-assembly to combat malaria","volume":"163","author":"Ismail","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2018.06.006","article-title":"Nanodisk-based glioma-targeted drug delivery enabled by a stable glycopeptide","volume":"284","author":"Wang","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0245","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1021\/acs.molpharmaceut.6b00818","article-title":"Minimum transendothelial electrical resistance thresholds for the study of small and large molecule drug transport in a human blood-brain barrier model","volume":"13","author":"Mantle","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0250","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1021\/acsnano.2c00320","article-title":"Brain-targeted codelivery of bcl-2\/bcl-xl and mcl-1 inhibitors by biomimetic nanoparticles for orthotopic glioblastoma therapy","volume":"16","author":"He","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0255","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.apsb.2020.02.001","article-title":"Impact of molecular weight on the mechanism of cellular uptake of polyethylene glycols (PEGs) with particular reference to p-glycoprotein","volume":"10","author":"Wang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0260","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1021\/acs.molpharmaceut.8b00612","article-title":"Effects of protein corona on active and passive targeting of cyclic RGD peptide-functionalized pegylation nanoparticles","volume":"15","author":"Su","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0265","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nano.2012.05.015","article-title":"Effect of ligand density, receptor density, and nanoparticle size on cell targeting","volume":"9","author":"Elias","year":"2013","journal-title":"Nanomed-Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0270","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1073\/pnas.1307152110","article-title":"Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor","volume":"110","author":"Wiley","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0275","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2024.06.005_bb0280","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13346-019-00631-4","article-title":"Pegylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution","volume":"9","author":"Hussain","year":"2019","journal-title":"Drug Deliv. Transl. Re."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0285","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s44222-023-00138-1","article-title":"Controlling the biodistribution and clearance of nanomedicines","volume":"2","author":"Cabral","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0290","doi-asserted-by":"crossref","first-page":"114895","DOI":"10.1016\/j.addr.2023.114895","article-title":"Stealth and pseudo-stealth nanocarriers","volume":"198","author":"Wen","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.06.005_bb0295","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1039\/C5CC06661A","article-title":"Enhanced target recognition of nanoparticles by cocktail pegylation with chains of varying lengths","volume":"52","author":"Ishii","year":"2016","journal-title":"Chem. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592400347X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592400347X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T10:04:32Z","timestamp":1728122672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592400347X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":59,"alternative-id":["S016836592400347X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.005","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEG length effect of peptide-functional liposome for blood brain barrier (BBB) penetration and brain targeting","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}